» Articles » PMID: 38929164

The Antioxidant Potential and Anticancer Activity of Ethanolic Extract Against Triple-Negative Breast Cancer Cells

Overview
Date 2024 Jun 27
PMID 38929164
Authors
Affiliations
Soon will be listed here.
Abstract

Natural remedies have been indispensable to traditional medicine practices for generations, offering therapeutic solutions for various ailments. In modern times, these natural products continue to play a pivotal role in the discovery of new drugs, especially for cancer treatment. The marine ecosystem offers a wide range of plants with potential anticancer activities due to their distinct biochemical diversity and adaptation to extreme situations. The seagrass is rich in diverse bioactive metabolites that bestow the plant with various pharmacological properties. However, its anticancer activity against invasive triple-negative breast cancer (TNBC) is still poorly investigated. In the present study, the phytochemical composition of an ethanolic extract of (HUE) was screened, and its antioxidant potential was evaluated. Moreover, the anticancer potential of HUE against MDA-MB-231 cells was investigated along with the possible underlying mechanisms of action. Our results showed that HUE is rich in diverse phytochemicals that are known for their antioxidant and anticancer effects. In MDA-MB-231 cells, HUE targeted the hallmarks of cancer, including cell proliferation, adhesion, migration, invasion, and angiogenesis. The HUE-mediated anti-proliferative and anti-metastatic effects were associated with the downregulation of the proto-oncogenic STAT3 signaling pathway. Taken together, could serve as a valuable source for developing novel drugs targeting TNBC.

Citing Articles

Potential Use of Marine Plants as a Source of Bioactive Compounds.

Ribas-Taberner M, Mir-Rossello P, Gil L, Sureda A, Capo X Molecules. 2025; 30(3).

PMID: 39942590 PMC: 11821081. DOI: 10.3390/molecules30030485.


Halodule uninervis extract facilitates the green synthesis of gold nanoparticles with anticancer activity.

Wehbe N, Mesmar J, El Kurdi R, Al-Sawalmih A, Badran A, Patra D Sci Rep. 2025; 15(1):4286.

PMID: 39905108 PMC: 11794841. DOI: 10.1038/s41598-024-81875-0.


A Phytochemical Analysis and the Pharmacological Implications of the Seagrass : An Overview.

Wehbe N, Bechelany M, Badran A, Al-Sawalmih A, Mesmar J, Baydoun E Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204098 PMC: 11357459. DOI: 10.3390/ph17080993.

References
1.
Prince Vijeya Singh J, Selvendiran K, Banu S, Padmavathi R, Sakthisekaran D . Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine. 2004; 11(4):309-14. DOI: 10.1078/0944711041495254. View

2.
Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, Nebreda A . p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol Cell Biol. 2009; 29(16):4341-51. PMC: 2725730. DOI: 10.1128/MCB.00210-09. View

3.
Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

4.
Bianchini G, Balko J, Mayer I, Sanders M, Gianni L . Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016; 13(11):674-690. PMC: 5461122. DOI: 10.1038/nrclinonc.2016.66. View

5.
Slika H, Mansour H, Wehbe N, Nasser S, Iratni R, Nasrallah G . Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022; 146:112442. DOI: 10.1016/j.biopha.2021.112442. View